Evidence map›Paper›PMID 35137366›Full record

ReviewAdvances in experimental medicine and biology2021

Outbreak of COVID-19: A Detailed Overview and Its Consequences.

Saurabh Shivalkar, M Shivapriya Pingali, Arushi Verma, Anirudh Singh, Vishal Singh, Biswaranjan Paital, Debashis Das, Pritish Kumar Varadwaj, Sintu Kumar Samanta

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
27.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.Clinical, cosmetic and investigational dermatology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Saurabh ShivalkarDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Allahabad, India.
M Shivapriya PingaliDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Allahabad, India.
Arushi VermaDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Allahabad, India.
Anirudh SinghDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Allahabad, India.
Vishal SinghDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Allahabad, India.
Biswaranjan PaitalReodx Regulation Laboratory, Department of Zoology, College of Basic Science and Humanities, Odisha University of Agriculture and Technology, Bhubaneswar, Odisha, India. biswaranjanpaital@gmail.com.
Debashis DasDepartment of Botany, College of Basic Science and Humanities, Odisha University of Agriculture and Technology, Bhubaneswar, Odisha, India.
Pritish Kumar VaradwajDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Allahabad, India. pritish@iiita.ac.in.
Sintu Kumar SamantaDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Allahabad, India. samantasintu@iiita.ac.in.
Indian Institute of Information Technology Allahabad · INOdisha University of Agriculture and Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAfter the outbreak from Wuhan City of China, COVID-19, caused by SARS-CoV-2, has become a pandemic worldwide in a very short span of time. The high transmission rate and pathogenicity of this virus have made COVID-19 a major public health concern globally. Basically, the emergence of SARS-CoV-2 is the third introduction of a highly infectious human epidemic coronavirus in the twenty-first century. Various research groups have claimed bats to be the natural host of SARS-CoV-2. However, the intermediate host and mode of transmission from bat to humans are not revealed yet. The COVID-19 cost hundreds and thousands of lives and millions are facing the consequences. The objective of this chapter was to analyze the outbreak of COVID-19 and problems faced globally.

methodsAll published relevant literature from scientific sources and reputed news channels are considered to write the current review.

resultsGenerally, elder persons and more particularly people with underlying medical conditions are found to be highly vulnerable to severe infection and prone to fatal outcomes. Unfortunately, there is no specific treatment with clinically approved drugs or vaccines to treat this disease. Several research groups have been investigating the efficacies of several antiviral and repurposed drugs. Currently, most of the SARS-COV-2 vaccines are at the preclinical or clinical stage of development. The latest research progress on the epidemiology, clinical characteristics, pathogenesis, diagnosis, and current status of therapeutic intervention indicates that still a specific drug or vaccine needs to come up for the effective treatment of the pandemic COVID-19. It is observed that various aspects of social life, economic status, and healthcare systems are majorly affected by this pandemic.

conclusionIt is concluded that the outbreak of COVID-19 has severely affected each and every field, such as social, scientific, industrial, transport, and medical sectors. Irrespective of tremendous efforts globally, few vaccines are now available for the prevention of the disease. Specific drug is not available publicly for the treatment of COVID-19. Prevention of air pollution that can aggravate COVID-19 has been suggested. Therefore, as of now, social distancing and sanitization practices are the only options available for the prevention of the disease for many.

Indexed as

COVID-19AgedCOVID-19 VaccinesDisease OutbreaksHumansPandemicsSARS-CoV-2COVID-19 VaccinesCOVID-19EpidemiologySARS-COV-2Socioeconomic impactsTherapeuticsVaccine development

Identifiers

PMID35137366
OpenAlexW4210853599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.